InChI=1S/C49H85O13P/c1- 3- 5- 7- 9- 11- 13- 15- 17- 19- 21- 23- 25- 27- 29- 31- 33- 35- 37- 42(50) 59- 39- 41(40- 60- 63(57,58) 62- 49- 47(55) 45(53) 44(52) 46(54) 48(49) 56) 61- 43(51) 38- 36- 34- 32- 30- 28- 26- 24- 22- 20- 18- 16- 14- 12- 10- 8- 6- 4- 2/h5,7,11,13,17- 20,23,25,41,44- 49,52- 56H,3- 4,6,8- 10,12,14- 16,21- 22,24,26- 40H2,1- 2H3,(H,57,58) /b7- 5- ,13- 11- ,19- 17- ,20- 18- ,25- 23- /t41- ,44- ,45- ,46+,47- ,48- ,49- /m1/s1 |
DFVYHWRJXSIHDY-IDUKVEHYSA-N |
C(C/C=C\CCCCCCCC) CCCCCCCC(O[C@@H] (COP(O[C@H] 1[C@@H] ([C@H] ([C@@H] ([C@H] ([C@H] 1O) O) O) O) O) (=O) O) COC(CCCCCC/C=C\C/C=C\C/C=C\C/C=C\CC) =O) =O |
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
|
|
View more via ChEBI Ontology
Outgoing
|
1- [(8Z,11Z,14Z,17Z)- icosatetraenoyl]- 2- [(11Z)- icosenoyl]- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89243)
has functional parent
(11Z)-icos-11-enoic acid
(CHEBI:32425)
1- [(8Z,11Z,14Z,17Z)- icosatetraenoyl]- 2- [(11Z)- icosenoyl]- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89243)
has functional parent
all-cis-8,11,14,17-icosatetraenoic acid
(CHEBI:71488)
1- [(8Z,11Z,14Z,17Z)- icosatetraenoyl]- 2- [(11Z)- icosenoyl]- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89243)
has role
human metabolite
(CHEBI:77746)
1- [(8Z,11Z,14Z,17Z)- icosatetraenoyl]- 2- [(11Z)- icosenoyl]- sn- glycero- 3- phospho- 1D- myo- inositol
(CHEBI:89243)
is a
1-phosphatidyl-1D-myo-inositol
(CHEBI:16749)
|
|
(2R)- 3- [(hydroxy{[(1S,2R,3R,4S,5S,6R)- 2,3,4,5,6- pentahydroxycyclohexyl]oxy}phosphoryl)oxy]- 2- {[(11Z)- icos- 11- enoyl]oxy}propyl (8Z,11Z,14Z,17Z)- icosa- 8,11,14,17- tetraenoate
|
1-(8Z,11Z,14Z,17Z-Eicosapentaenoyl)-2-(11Z-eicosenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
HMDB
|
1-Eicsoatetraenoyl-2-eicosenoyl-sn-glycero-3-phosphoinositol
|
HMDB
|
[(2R)- 2- [(11Z)- icos- 11- enoyloxy]- 3- [(8Z,11Z,14Z,17Z)- icosa- 8,11,14,17- tetraenoyloxy]propoxy]({[(1s,3R)- 2,3,4,5,6- pentahydroxycyclohexyl]oxy})phosphinic acid
|
HMDB
|
Phosphatidylinositol(20:4/20:1)
|
HMDB
|
Phosphatidylinositol(20:4n3/20:1n9)
|
HMDB
|
Phosphatidylinositol(20:4w3/20:1w9)
|
HMDB
|
Phosphatidylinositol(40:5)
|
HMDB
|
PI(20:4(8Z,11Z,14Z,17Z)/20:1(11Z))
|
HMDB
|
PI(20:4/20:1)
|
HMDB
|
PI(20:4n3/20:1n9)
|
HMDB
|
PI(20:4w3/20:1w9)
|
HMDB
|
PI(40:5)
|
HMDB
|
PIno(20:4/20:1)
|
HMDB
|
PIno(20:4n3/20:1n9)
|
HMDB
|
PIno(20:4w3/20:1w9)
|
HMDB
|
PIno(40:5)
|
HMDB
|
20671299
|
PubMed citation
|
Europe PMC
|
|